Jupiter Life Line Hospitals Limited
Fundamental Score
Jupiter Life Line Hospitals Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of JLHL across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Excellent ROCE Performance (17.95%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (21.60%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Strong Revenue Growth (17.48%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (22.20% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (36.51% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (43.62% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (11.82x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Institutional Confidence (FII+DII: 26.03%)
Observation: Significant professional investor participation indicates quality recognition.
Analysis: High institutional holding often signals thorough due diligence and quality business fundamentals.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
3 factors identified
Premium Valuation Risk (P/E: 48.76x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Negative Free Cash Flow (₹-69.50 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Financial Statements
Comprehensive financial data for Jupiter Life Line Hospitals Limited
About JLHL
Business Overview
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.
Company Details
Key Leadership
Corporate Events
JLHL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Jupiter Life Line Hospitals Limited (JLHL)?
As of 30 Jan 2026, 01:39 pm IST, Jupiter Life Line Hospitals Limited (JLHL) is currently trading at ₹1351.20. The stock has a market capitalization of ₹9.68K (Cr).
Is JLHL share price Overvalued or Undervalued?
JLHL is currently trading at a P/E ratio of 48.76x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Jupiter Life Line Hospitals Limited share price?
Key factors influencing JLHL's price include its quarterly earnings growth (Sales Growth: 17.48%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Jupiter Life Line Hospitals Limited a good stock for long-term investment?
Jupiter Life Line Hospitals Limited shows a 5-year Profit Growth of 43.62% and an ROE of 14.95%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing.
How does Jupiter Life Line Hospitals Limited compare with its industry peers?
Jupiter Life Line Hospitals Limited competes with major peers in the Hospital. Investors should compare JLHL's P/E of 48.76x and ROE of 14.95% against the industry averages to determine its competitive standing.
What is the P/E ratio of JLHL and what does it mean?
JLHL has a P/E ratio of 48.76x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹49 for every ₹1 of annual earnings.
How is JLHL performing according to Bull Run's analysis?
JLHL has a Bull Run fundamental score of 62.9/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does JLHL belong to?
JLHL operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Jupiter Life Line Hospitals Limited.
What is Return on Equity (ROE) and why is it important for JLHL?
JLHL has an ROE of 14.95%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Jupiter Life Line Hospitals Limited generates profits from shareholders' equity.
How is JLHL's debt-to-equity ratio and what does it indicate?
JLHL has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is JLHL's dividend yield and is it a good dividend stock?
JLHL offers a dividend yield of 0.07%, which means you receive ₹0.07 annual dividend for every ₹100 invested.
How has JLHL grown over the past 5 years?
JLHL has achieved 5-year growth rates of: Sales Growth 22.20%, Profit Growth 43.62%, and EPS Growth 36.51%.
What is the promoter holding in JLHL and why does it matter?
Promoters hold 40.91% of JLHL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is JLHL's market capitalization category?
JLHL has a market capitalization of ₹9678 crores, placing it in the Mid-cap category.
How volatile is JLHL stock?
JLHL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for JLHL?
JLHL has a 52-week high of ₹N/A and low of ₹N/A.
What is JLHL's operating profit margin trend?
JLHL has a 5-year average Operating Profit Margin (OPM) of 21.60%, indicating the company's operational efficiency.
How is JLHL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 17.48% and YoY Profit Growth of 11.04%.
What is the institutional holding pattern in JLHL?
JLHL has FII holding of 9.06% and DII holding of 16.97%. Significant institutional holding often suggests professional confidence in the stock.